IMPRINTED GENES AS EPIGENETIC MARKERS FOR USE IN CLONING AND REGENERATIVE CELL PROCEDURES
In general, the invention features methods of identifying and/or preparing a mammalian cell or a cell population (e.g., bovine or porcine cells) for use in cloning procedures or regenerative cell procedures using expression of one or more of the epigenetic markers, IGF2, p57, and NNAT.
1 . A method for identifying a mammalian cell for use in a cloning procedure or a regenerative cell procedure comprising the steps of:
a) measuring the expression level of insulin-like growth factor-2 (IGF2) in the cell;
b) measuring the expression level of p57 in the cell; and
c) determining the ratio of the expression level of IGF2 to p57 in the cell, wherein an IGF2 to p57 ratio of less than or equal to 9 identifies a cell for use in a cloning procedure or a regenerative cell procedure.
2 . The method of claim 1 , wherein said method identifies a mammalian cell having at least a 40% probability of resulting in the generation of a viable embryo, a viable offspring, or a genetically-stable regenerative cell culture.
3 . The method of claim 1 , wherein said cloning procedure or regenerative cell procedure comprises the steps of permeabilizing a cell and incubating the cell with a cell extract.
4 . The method of claim 1 , wherein said method results in the generation of a genetically-stable regenerative cell culture.
5 . The method of claim 1 , wherein said mammalian cell is an ungulate cell.
6 . The method of claim 5 , wherein said ungulate cell is a bovine, porcine, ovine, or caprine cell.
7 . The method of claim 5 , wherein said method is a regenerative cell procedure and said cell is a human cell.
8 . A method for identifying a mammalian cell for use in a cloning procedure or a regenerative cell procedure comprising the step of determining whether the cell has mono-allelic expression of the neuronatin (NNAT) gene, wherein mono-allelic expression of NNAT identifies a cell for use in a cloning procedure or a regenerative cell procedure.
9 . The method of claim 8 , wherein said method identifies a mammalian cell having at least a 50% probability of resulting in the generation of a viable embryo, a viable offspring, or a genetically-stable regenerative cell culture.